Patalinghog, Venus .
HRN: 26-09-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/01/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/01/2024
11/07/2024
IV
2.25mg
Q8h
Complicated UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes